Company intelligence / Profile preview

Norwegian Biotech Center

Oslo, Oslo, Norway

Ownership: Private
Development stage: Other

Overview

Norwegian Biotech Center (NBC) is a biotechnology company based in Oslo, Norway, that specializes in providing high-quality research services and products to the life sciences community. The company focuses on the development and distribution of biochemicals, reagents, and specialized kits for molecular biology and proteomics research. NBC serves as a bridge between innovative biotechnology research and commercial application, offering consultancy and laboratory services to support drug discovery and diagnostic development. Their expertise spans across various therapeutic areas, providing essential tools for academic and industrial researchers in the Nordic region and beyond.

Modalities: Small moleculePeptidesProteins
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Norwegian Biotech Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norwegian Biotech Center.

Explore the full profile